Search

everythinglearnresearchcommunity

for

Search:↓

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Daughters of women with PCOS generally experience normal puberty but may have more body hair and different body fat distribution.

Testosterone may have a dual role in COVID-19, potentially worsening outcomes in men, and testosterone therapy could help some patients, but more research is needed.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

The hair serum significantly improved hair growth and reduced hair fall without causing any skin issues.

Siblings with signs of virilization should be tested for non-classical congenital adrenal hyperplasia, which does not affect adult height but may impact fertility and well-being if untreated.

Anti-Müllerian hormone is a specific marker for ovarian issues in women with conditions like PCOS.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

Women with PCOS have a higher risk of metabolic syndrome and need lifestyle changes and treatment.

The document explains how male reproductive hormones work and affect the body.

Up to half of adult women may experience hair loss, and doctors should use medical history, exams, and tests to find the cause and treat it.

Auto-portraits help evaluate scalp hair.

Most women with excess hair growth have an underlying hormonal issue, often treated with medication and hair removal methods.

Weight loss and metformin don't significantly change vaspin levels in women with PCOS.

Most hirsutism cases are due to PCOS, and treatment focuses on lowering testosterone and blocking its effects.

Hormones and genetics play key roles in male and female baldness, which can affect mental health and may be linked to other health issues.

New pregnane derivatives were more effective than finasteride at inhibiting a key enzyme for male pattern baldness.

Women with PCOS have higher levels of a certain growth factor, which can be reduced by taking metformin.

Oral isotretinoin for severe acne can change hormone levels but does not significantly affect ovarian function.

Hirsutism in women often indicates a hormonal imbalance and can be managed with a combination of hormonal treatments and hair removal methods.

5α-Reductase inhibitors do not consistently increase testosterone levels in the blood.

Medications for PCOS don't seem to raise heart disease risk.

Finasteride gel effectively and safely reduces hair thickness in women with excessive hair growth.

Patients with acne vulgaris have lower serum irisin levels.

Guidelines for diagnosing common hair loss include detailed history, clinical examination, and various diagnostic techniques.

Women with epilepsy should be monitored for reproductive issues, which can be caused by epilepsy or its treatments, especially when using valproate.

People with diabetes or obesity should manage their conditions carefully as they have a higher risk of severe COVID-19.

The testosterone patch and gel are both effective, but they have different absorption patterns and effects on hormone levels.

RU58841, a nonsteroidal anti-androgen, showed potential as a topical treatment for hair loss, increasing hair density, thickness, and length without systemic side effects in Stumptailed Macaques.

The document concludes that non-operative treatment for gender dysphoria is safe and effective, and hormone therapy does not increase cancer risk.